Overview

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Status:
Completed
Trial end date:
2002-09-11
Target enrollment:
Participant gender:
Summary
RATIONALE: Megestrol helps improve appetite. It is not yet known if megestrol is effective in limiting weight loss in patients who are undergoing radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in limiting weight loss in patients who are undergoing radiation therapy for lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Wake Forest Baptist Health
Wake Forest University Health Sciences
Collaborator:
National Cancer Institute (NCI)
Treatments:
Megestrol
Megestrol Acetate